Skip to content

13F-HR filed by Essex Woodlands Management, Inc.

Essex Woodlands Management, Inc. filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 10 holding rows worth $444,696,000.

Accession
0001398344-22-002910
Filed
2022-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A holdings report, 10 entries on the cover page, a total value of $444,696,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $444,697,000 with VALUE read as thousands by filing date, 13F file number 028-14839. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BIOVENTUS INC09075A108COM CL A12,096,702$175,281,000thousands by filing date
MIMEDX GROUP INC602496101COM23,376,623$141,195,000thousands by filing date
EYEPOINT INC COM NEW30233G209Stock4,190,921$51,297,000thousands by filing date
VENUS CONCEPT INC92332W105COM21,169,457$27,774,000thousands by filing date
TELA BIO INC872381108COM1,906,228$24,400,000thousands by filing date
SONENDO INC835431107Common Stocks1,992,526$11,477,000thousands by filing date
REVANCE THERAPEUTICS INC761330109COM457,085$7,460,000thousands by filing date
MEDICINOVA INC58468P206COM NEW1,105,941$2,964,000thousands by filing date
AXOGEN INC05463X106COM296,416$2,777,000thousands by filing date
CATALYST BIOSCIENCES INC14888D208COM78,622$72,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001398344-22-002910this filing2022-02-14acceptance time not in the bulk data set